Latest / Breaking News To Trading Moves
Medtronic Analysis: Procedural Growth Versus Guidance Headwinds
Medtronic beats, but the stock drops on guidance and cost headlines
What happened
Medtronic ($MDT) beat quarterly profit expectations on strong demand for cardiovascular devices (notably cardiac ablation / PFA) and solid procedure volumes, but shares slipped after the company kept full-year EPS guidance unchanged and flagged cost headwinds (tax, tariffs).
Why markets care
This is a “demand is strong, but the bar is higher” print. It supports the theme that procedure volumes are healthy across medtech, yet investors are quick to punish conservative guidance and cost uncertainty.
Winners…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.